Additionally, steatohepatitis was noted to reduce the ability of immunotherapeutic agents thereby inhibiting hepatic tumor growth through reduction of tumor infiltration by CD4+ T cells and effector memory cells (Ma et al., 2016; Brown et al., 2018; Heinrich et al., 2021). The gene discussed is CD4; the disease is neoplasm.